In 2023, roughly one independent pharmacy closed every day, and similar closures are anticipated this year, as noted by the National Association of Community Pharmacists.
Rite Aid has filed for Chapter 11 bankruptcy for the second time in just two years.
The pharmacy chain announced its bankruptcy filing on Monday, stating in a release that it aims to “substantially pursue a strategic and value-maximizing sales process for all assets.”
“For over 60 years, Rite Aid has proudly delivered pharmacy services and products to our loyal customers,” remarked Matt Schroeder, the CEO of Rite Aid.
While previous restructuring efforts had helped reduce debt within U.S. pharmacy chains, they didn’t fully tackle long-standing business challenges—especially with increasing competition from chains like Walgreens, CVS, Walmart, and Amazon.
Rite Aid is expected to close two or more stores as part of its bankruptcy proceedings.
Despite navigating economic hurdles heightened by the fast-changing retail and healthcare markets, the company expressed optimism due to interest from various potential national and regional acquirers.
Following its bankruptcy protection filing on October 11, 2023, Rite Aid found itself still carrying a $2.5 billion debt as it emerged from bankruptcy as a lender-owned private entity in 2024.
Currently, drugstore chains are facing their second bankruptcy, largely attributed to their limited retail footprint. In 2023, Rite Aid had about 2,000 pharmacies; that number has dwindled to just 1,240 in the U.S. Recent closures have significantly impacted their presence in states like Ohio and Michigan.
Rite Aid reiterated that “customers will continue to have access to pharmacy services and products in stores and online, including prescriptions and vaccinations.”
The company assured that its employees would “continue to receive their salary and benefits” while also managing the transfer of customer prescriptions to other pharmacies.
